These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 496568

  • 1. [Experiences with an enzyme cytochemical test for tumor cells in pleural fluid and ascites (author's transl)].
    Eckert H, Wildner GP.
    Arch Geschwulstforsch; 1979; 49(4):305-10. PubMed ID: 496568
    [Abstract] [Full Text] [Related]

  • 2. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA, Ehya H, Lang WR.
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
    Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF.
    Cancer Res; 1993 Jun 15; 53(12):2912-8. PubMed ID: 8504432
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP, Baxevanis CN, Papadopoulos NG, Zarkadis IK, Papacostas P, Michailakis E, Tsiatas ML, Papamichail M.
    Anticancer Res; 1996 Jun 15; 16(6B):3855-60. PubMed ID: 9042270
    [Abstract] [Full Text] [Related]

  • 8. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
    van de Molengraft FJ, Vooijs GP.
    Acta Cytol; 1988 Jun 15; 32(2):183-7. PubMed ID: 3348059
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.
    Sairenji M, Suzuki K, Murakami K, Motohashi H, Okamoto T, Umeda M.
    Jpn J Cancer Res; 1987 Aug 15; 78(8):814-8. PubMed ID: 3115927
    [Abstract] [Full Text] [Related]

  • 11. A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions.
    Gioanni J, Caldani C, Zanghellini E, Mazeau C, Duplay H, Ferrua B, Schneider M.
    Acta Cytol; 1991 Aug 15; 35(3):315-9. PubMed ID: 2042433
    [Abstract] [Full Text] [Related]

  • 12. Electron microscopic studies of cells in pleural and peritoneal effusions.
    Murad TM.
    Acta Cytol; 1973 Aug 15; 17(5):401-9. PubMed ID: 4517952
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H, Rona G, Hutter C, Bayer PM, Kummer F.
    Wien Klin Wochenschr; 1986 Sep 12; 98(17):564-73. PubMed ID: 3020811
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
    Kyrkou KA, Iatridis SG, Athanassiadou PP, Athanassiadis PP, Mandragos CE.
    Cancer Detect Prev; 1985 Sep 12; 8(1-2):247-54. PubMed ID: 4064045
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.